Yuru Deng

Dr. Yuru Deng

Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
YDYuru Deng
Yuru Deng
Angelina AngelovaAngelina Angelova
Angelina Angelova
Coronaviruses have lipid envelopes required for their activity. The fact that coronavirus infection provokes the formation of cubic membranes (CM) (denoted also as convoluted membranes) in host cells has not been rationalized in the development of antiviral therapies yet. In this context, the role of bioactive plasmalogens (vinyl ether glycerophospholipids) is not completely understood. These lipid species display a propensity for non-lamellar phase formation, facilitating membrane fusion, and modulate the activity of membrane-bound proteins such as enzymes and receptors. At the organism level, plasmalogen deficiency is associated with cardiometabolic disorders including obesity and type 2 diabetes in humans. A straight link is perceived with the susceptibility of such patients to SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) infection, the severity of illness, and the related difficulty in treatment. Based on correlations between the coronavirus-induced modifications of lipid metabolism in host cells, plasmalogen deficiency in the lung surfactant of COVID-19 patients, and the alterations of lipid membrane structural organization and composition including the induction of CM, we emphasize the key role of plasmalogens in the coronavirus (SARS-CoV-2, SARS-CoV, or MERS-CoV) entry and replication in host cells. Considering that plasmalogen-enriched lung surfactant formulations may improve the respiratory process in severe infected individuals, plasmalogens can be suggested as an anti-viral prophylactic, a lipid biomarker in SARS-CoV and SARS-CoV-2 infections, and a potential anti-viral therapeutic component of lung surfactant development for COVID-19 patients.

7 July 2023 in Brain Research Bulletin
Verified
Journal Article
Open access
ACAdriano Maia Chaves-Filho
Adriano Maia Chaves-Filho
OBOlivia Braniff
Olivia Braniff
Angelina AngelovaAngelina Angelova
Angelina Angelova
YDYuru Deng
Yuru Deng
MTMarie-Ève Tremblay
Marie-Ève Tremblay
After five waves of coronavirus disease 2019 (COVID-19) outbreaks, it has been recognized that a significant portion of the affected individuals developed long-term debilitating symptoms marked by chronic fatigue, cognitive difficulties ("brain fog"), post-exertional malaise, and autonomic dysfunction. The onset, progression, and clinical presentation of this condition, generically named post-COVID-19 syndrome, overlap significantly with another enigmatic condition, referred to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Several pathobiological mechanisms have been proposed for ME/CFS, including redox imbalance, systemic and central nervous system inflammation, and mitochondrial dysfunction. Chronic inflammation and glial pathological reactivity are common hallmarks of several neurodegenerative and neuropsychiatric disorders and have been consistently associated with reduced central and peripheral levels of plasmalogens, one of the major phospholipid components of cell membranes with several homeostatic functions. Of great interest, recent evidence revealed a significant reduction of plasmalogen contents, biosynthesis, and metabolism in ME/CFS and acute COVID-19, with a strong association to symptom severity and other relevant clinical outcomes. These bioactive lipids have increasingly attracted attention due to their reduced levels representing a common pathophysiological manifestation between several disorders associated with aging and chronic inflammation. However, alterations in plasmalogen levels or their lipidic metabolism have not yet been examined in individuals suffering from post-COVID-19 symptoms. Here, we proposed a pathobiological model for post-COVID-19 and ME/CFS based on their common inflammation and dysfunctional glial reactivity, and highlighted the emerging implications of plasmalogen deficiency in the underlying mechanisms. Along with the promising outcomes of plasmalogen replacement therapy (PRT) for various neurodegenerative/neuropsychiatric disorders, we sought to propose PRT as a simple, effective, and safe strategy for the potential relief of the debilitating symptoms associated with ME/CFS and post-COVID-19 syndrome.

1 May 2021 in Analytica Chimica Acta
Verified
Journal Article
Closed access
FDFeng Ding
Feng Ding
HWHan Wen
Han Wen
RZRuijiang Zhuo
Ruijiang Zhuo
JLJiawei Li
Jiawei Li
HZHui Zheng
Hui Zheng
XHXiaojun He
Xiaojun He

28 February 2020 in Science China Materials
Verified
Journal Article
Open access
PDF file
CCCongcong Cui
Congcong Cui
YDYuru Deng
Yuru Deng
LHLu Han
Lu Han
Nature has created innumerable life forms with miraculous hierarchical structures and morphologies that are optimized for different life events through evolution over billions of years. Bicontinuous cubic structures, which are often described by triply periodic minimal surfaces (TPMSs) and their constant mean curvature (CMC)/parallel surface companions, are of special interest to various research fields because of their complex form with unique physical functionalities. This has prompted the scientific community to fully understand the formation, structure, and properties of these materials. In this review, we summarize and discuss the formation mechanism and relationships of the relevant biological structures and the artificial self-assembly systems. These structures can be formed through biological processes with amazing regulation across a great length scales; nevertheless, artificial construction normally produces the structure corresponding to the molecular size and shape. Notably, the block copolymeric system is considered to be an applicable and attractive model system for the study of biological systems due to their versatile design and rich phase behavior. Some of the phenomena found in these two systems are compared and discussed, and this information may provide new ideas for a comprehensive understanding of the relationship between molecular shape and resulting interface curvature and the self-assembly process in living organisms. We argue that the co-polymeric system may serve as a model to understand these biological systems and could encourage additional studies of artificial self-assembly and the creation of new functional materials.

16 February 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
RZRuijiang Zhuo
Ruijiang Zhuo
PRPu Rong
Pu Rong
JWJieli Wang
Jieli Wang
RPRokshana Parvin
Rokshana Parvin
YDYuru Deng
Yuru Deng
Neonatal respiratory distress syndrome (NRDS) is a type of newborn disorder caused by the deficiency or late appearance of lung surfactant, a mixture of lipids and proteins. Studies have shown that lung surfactant replacement therapy could effectively reduce the morbidity and mortality of NRDS, and the therapeutic effect of animal-derived surfactant preparation, although with its limitations, performs much better than that of protein-free synthetic ones. Plasmalogens are a type of ether phospholipids present in multiple human tissues, including lung and lung surfactant. Plasmalogens are known to promote and stabilize non-lamellar hexagonal phase structure in addition to their significant antioxidant property. Nevertheless, they are nearly ignored and underappreciated in the lung surfactant-related research. This report will focus on plasmalogens, a minor yet potentially vital component of lung surfactant, and also discuss their biophysical properties and functions as anti-oxidation, structural modification, and surface tension reduction at the alveolar surface. At the end, we boldly propose a novel synthetic protein-free lung surfactant preparation with plasmalogen modification as an alternative strategy for surfactant replacement therapy.

28 February 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
YWYu Wu
Yu Wu
JWJieli Wang
Jieli Wang
YDYuru Deng
Yuru Deng
Borislav AngelovBorislav Angelov
Borislav Angelov
TFTakehiko Fujino
Takehiko Fujino
Angelina AngelovaAngelina Angelova
Angelina Angelova
Plasmalogens (vinyl‐ether phospholipids) are an emergent class of lipid drugs against various diseases involving neuro‐inflammation, oxidative stress, mitochondrial dysfunction, and altered lipid metabolism. They can activate neurotrophic and neuroprotective signaling pathways but low bioavailabilities limit their efficiency in curing neurodegeneration. Here, liquid crystalline lipid nanoparticles (LNPs) are created for the protection and non‐invasive intranasal delivery of purified scallop‐derived plasmalogens. The in vivo results with a transgenic mouse Parkinson's disease (PD) model (characterized by motor impairments and α‐synuclein deposition) demonstrate the crucial importance of LNP composition, which determines the self‐assembled nanostructure type. Vesicle and hexosome nanostructures (characterized by small‐angle X‐ray scattering) display different efficacy of the nanomedicine‐mediated recovery of motor function, lipid balance, and transcriptional regulation (e.g., reduced neuro‐inflammation and PD pathogenic gene expression). Intranasal vesicular and hexosomal plasmalogen‐based LNP treatment leads to improvement of the behavioral PD symptoms and downregulation of the Il6, Il33, and Tnfa genes. Moreover, RNA‐sequencing and lipidomic analyses establish a dramatic effect of hexosomal nanomedicines on PD amelioration, lipid metabolism, and the type and number of responsive transcripts that may be implicated in neuroregeneration.